Bain Capital Public Equity Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-250,656
Closed -$11.8M 74
2018
Q2
$11.8M Buy
250,656
+122,873
+96% +$6.93M 0.8% 27
2018
Q1
$6.64M Buy
+127,783
New +$6.9M 0.48% 42
2017
Q4
Sell
-140,524
Closed -$8.59M 96
2017
Q3
$8.59M Buy
+140,524
New +$8.52M 0.54% 42
2017
Q2
Sell
-156,571
Closed -$9.49M 66
2017
Q1
$9.49M Buy
+156,571
New +$9.5M 0.67% 35
2016
Q4
Sell
-2,126,267
Closed -$124M 60
2016
Q3
$127M Buy
+2,126,267
New +$124M 8.21% 2

Other funds holding MRK

Bain Capital Public Equity Management's MRK Position: Q3 2018 in Review

Bain Capital Public Equity Management sold out of Merck (MRK) in Q3 2018, closing a stake of 250,656 shares — an estimated $11.8M sold.

Bain Capital Public Equity Management first reported a position in MRK in Q3 2016 and held it in 5 quarters. The position peaked at $127M in Q3 2016. 2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

  • Bain Capital Public Equity Management reported no remaining Merck position as of Q3 2018 after selling out during the quarter.
  • Bain Capital Public Equity Management sold 250,656 Merck shares in Q3 2018, an estimated $11.8M.
  • Bain Capital Public Equity Management first reported a position in Merck in Q3 2016 and held it in 5 quarters.
  • Bain Capital Public Equity Management's Merck position peaked at $127M in Q3 2016.
  • 2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on Bain Capital Public Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.